书目名称 | Malignant Pleural Mesothelioma | 副标题 | Advances in Pathogen | 编辑 | Takashi Nakano,Takashi Kijima | 视频video | | 概述 | Provides essential information on molecular genetics, epidemiology, translational research, and the latest results of clinical trials on mesothelioma.Consists of 5 themed sections: epidemiology, patho | 丛书名称 | Respiratory Disease Series: Diagnostic Tools and Disease Managements | 图书封面 |  | 描述 | This book provides essential information on recent advances in molecular genetics, epidemiology, translational research, and the latest results of clinical trials on mesothelioma. Significant progress has been made in understanding mesothelioma biology, and in developing new therapies for this refractory tumor, malignant pleural mesothelioma (MPM). Not only does this volume summarize the latest research-based data on the disease; it also shares insights into future research directions..The book consists of 5 themed sections on: epidemiology, pathogenesis, screening and early detection, molecular genetics, and clinical aspects and management. Several chapters focus on new trends in the field, e.g. immune therapy and identification of biomarkers, molecular oncogenesis including genetic susceptibility, and molecular diagnostic pathology. The book also highlights new cancer treatment approaches, such as immunotherapy based on immune checkpoint inhibitors, which has meanta paradigm shift in other types of cancer, and given some hope to MPM patients. In turn, it discusses recent molecular pathological studies on mesothelioma, which claim to offer more accurate classifications than tradit | 出版日期 | Book 2021 | 关键词 | Asbestos; Biomolecular Pathways; Pleural Plaque; Cancer Screening; Cytopathologic Diagnosis; Liquid Biops | 版次 | 1 | doi | https://doi.org/10.1007/978-981-15-9158-7 | isbn_softcover | 978-981-15-9160-0 | isbn_ebook | 978-981-15-9158-7Series ISSN 2509-5552 Series E-ISSN 2509-5560 | issn_series | 2509-5552 | copyright | Springer Nature Singapore Pte Ltd. 2021 |
The information of publication is updating
|
|